Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
029
|
Date of Entry 08/20/2012
|
FR Recognition Number
|
3-104
|
Standard | |
ASTM F2914-12 (Reapproved 2018) Standard Guide for Identification of Shelf-life Test Attributes for Endovascular Devices |
|
Scope/AbstractThis guide addresses the determination of appropriate device attributes for testing as part of a shelf-life study for endovascular devices. Combination and biodegradable devices (for example drug-devices, biologic devices or drug biologics) may require additional considerations, depending on their nature. |
|
Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§870.3375 |
Filter, Intravascular, Cardiovascular
|
Class 2
|
DTK
|
N/A |
Stent, Coronary |
Class 3
|
MAF
|
N/A |
System, Endovascular Graft, Aortic Aneurysm Treatment |
Class 3
|
MIH
|
N/A |
Transcatheter Septal Occluder |
Class 3
|
MLV
|
N/A |
Stent, Carotid |
Class 3
|
NIM
|
N/A |
Stent, Renal |
Class 3
|
NIN
|
N/A |
Stent, Iliac |
Class 3
|
NIO
|
N/A |
Stent, Superficial Femoral Artery |
Class 3
|
NIP
|
N/A |
Coronary Drug-Eluting Stent |
Class 3
|
NIQ
|
|
Relevant FDA Guidance and/or Supportive Publications*
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |